See what’s happening at MBC BioLabs.

Featured News

Featured News

2025 Astellas Future Innovator Prize Awarded to DeepSeq.AI & Serna Bio

The award, now in its sixth year, offers entrepreneurial scientists, emerging startups and small biotechs one-year priority usage of MBC BioLabs’ state-of-the-art lab facility in the San Francisco Bay Area, as well as access to Astellas’ research and development capabilities and business leaders.

ONO Golden Ticket 2025

ONO PHARMA USA announced partnerships with LabCentral in Cambridge, Mass., and MBC BioLabs in San Francisco and San Carlos, CA to award each organization one Golden Ticket for an innovative life sciences startup company.

Interested applicants may submit their non-confidential company presentations by June 6.

Astellas Future Innovator Prize 2025

Astellas Pharma U.S. Inc., and MBC BioLabs announced their collaboration on the Astellas Future Innovator Prize. The competition offers entrepreneurial scientists and emerging biotechnology start-ups one year’s priority usage of MBC BioLabs’ state-of-the-art Bay Area facilities and access to Astellas’ research and development capabilities and business leaders.

Proposals due by April 1, 2025

  • The award, now in its sixth year, offers entrepreneurial scientists, emerging startups and small biotechs one-year priority usage of MBC BioLabs’ state-of-the-art lab facility in the San Francisco Bay Area, as well as access to Astellas’ research and development capabilities and business leaders.

  • ONO PHARMA USA announced partnerships with LabCentral in Cambridge, Mass., and MBC BioLabs in San Francisco and San Carlos, CA to award each organization one Golden Ticket for an innovative life sciences startup company.

    Interested applicants may submit their non-confidential company presentations by June 6.

  • Astellas Pharma U.S. Inc., and MBC BioLabs announced their collaboration on the Astellas Future Innovator Prize. The competition offers entrepreneurial scientists and emerging biotechnology start-ups one year’s priority usage of MBC BioLabs’ state-of-the-art Bay Area facilities and access to Astellas’ research and development capabilities and business leaders.

    Proposals due by April 1, 2025

Breakfast of Champions | Breaking Barriers in Cell & Gene Therapy

July 29 @ 9:30 pm – 1 pm

Location:
1030 Brittan Ave · San Carlos

Breakfast of Champions | Breaking Barriers in Cell & Gene Therapy

July 31 @ 9:30 am – 1pm

Location:
135 Mississippi St · San Francisco

  • Dr. Kristen Hege – Pioneering Car-T Cell Therapy in Oncology

    Dr. Kristen Hege delivered a memorable keynote to our community, sharing wisdom gained from her transformative journey through academic medicine and biotech leadership.

  • Brazilian Delegation Visits MBC BioLabs to Explore the Future of Biotech

    The delegation was given an immersive tour of the facilities, showcasing cutting-edge laboratories, co-working spaces, and support services that MBC BioLabs offers to its resident companies.

  • Fika, A New MBC BioLabs Tradition!

    According to Doug Crawford, there are a few key things that scientists need in order to succeed in the labs: one of them being coffee, and the other is snacks! Our newly adapted weekly tradition of Fika was inspired by the Swedish culture. Fika, which roughly translates from Swedish as drinking coffee, munching sweet treats and chatting — is as much a part of the working day in Sweden as emailing and fixing the printer.

  • Ambagon Therapeutics

    By taming disordered proteins, Ambagon generates new possibilities across the proteome.